Catalog Home Page

Restoration of defective cross-presentation in tumors by gemcitabine

McDonnell, A.M, Joost Lesterhuis, W., Khong, A., Nowak, A.K, Lake, R.A., Currie, A.J. and Robinson, B.W.S. (2015) Restoration of defective cross-presentation in tumors by gemcitabine. OncoImmunology, 4 (5).

PDF - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (130kB)
Free to read:
*No subscription required


Tumor antigen cross-presentation by dendritic cells (DCs) to specific CD8(+) T cells is central to antitumor immunity. Although highly efficient in draining lymph nodes, it is defective within the tumor site itself. Importantly, an immunogenic chemotherapy, gemcitabine, reverses this defect, allowing the potential re-stimulation of cytotoxic T lymphocytes within tumor sites.

Item Type: Journal Article
Murdoch Affiliation: School of Veterinary and Life Sciences
Publisher: Taylor & Francis
Copyright: © The Authors
Item Control Page Item Control Page


Downloads per month over past year